- You are here:
- Home »
- Blog »
- ovarian cancer »
- Ovarian Cancer – Need to Know
Ovarian Cancer – Need to Know
Ovarian Cancer – Need to Know: A diagnosis of ovarian cancer can feel overwhelming. Although treatment options have improved over time, understanding what ovarian cancer is, who’s at risk, how it’s diagnosed, and what conventional and supportive care options exist can help you or a loved one make informed decisions.
Ovarian cancer occurs when cells in the ovaries begin to grow abnormally and invade nearby tissues or spread into other parts of the body. It isn’t just one disease—there are several types of ovarian cancer, with the most common originating in the epithelial cells that cover the ovary or fallopian tube.
This post explains the essentials of ovarian cancer and highlights important considerations, from diagnosis to treatment and survivorship.
Be sure to watch each of the videos about:
I am a long-term survivor of an incurable blood cancer called multiple myeloma. My research and experience with evidence-based non-conventional therapies is the reason I have lived in complete remission from my incurable cancer. I have learned that the best way to manage cancer is to combine the best of conventional and evidence-based non-conventional therapies.
Scroll down the page and post a question or comment if there’s anything you’d like to know about thyroid cancer.
Good luck,
David Emerson
- Cancer Survivor
- Cancer Coach
- Director PeopleBeatingCancer
🩺 Ovarian Cancer in Numbers
Ovarian cancer is not among the most common cancers overall, but it is one of the leading causes of cancer-related deaths in women because it’s often detected at a later stage. In the United States in 2026, an estimated about 21,010 women will be newly diagnosed with ovarian cancer and approximately 12,450 will die from it, according to the latest estimates. The lifetime risk of developing ovarian cancer is roughly 1 in 91, and the lifetime risk of dying from it is about 1 in 143.
🔍 What Is Ovarian Cancer?
Ovarian cancer refers to malignant cells that originate in ovarian tissue. These tissues include:
- Epithelial cells, which cover the ovary’s surface (most cases)
- Germ cells, which produce eggs
- Stromal cells, which make hormones and support ovarian structure
Because symptoms are often subtle or similar to common digestive or reproductive issues, ovarian cancer can be difficult to detect early.
🧬 Risk Factors: Who’s More Likely to Get It?
A risk factor increases the chance of developing ovarian cancer but does not guarantee the disease will occur. Many people with ovarian cancer have few known risk factors, and many with risk factors never get the disease.
Commonly recognized risk factors include:
- Older age – most cases are diagnosed after menopause.
- Inherited gene mutations (e.g., BRCA1, BRCA2, Lynch syndrome).
- Family history of ovarian or related cancers.
- Reproductive history (never having been pregnant).
- Endometriosis and some hormone exposures.
- Age at first menstruation or last menopause (longer lifetime exposure to hormones).
Note: Most women who get ovarian cancer are not at high risk, and risk factors don’t function like a checklist.
🚨 Common Symptoms
Early ovarian cancer may cause vague or intermittent symptoms that can be mistakenly attributed to less serious conditions. However, persistent or worsening patterns warrant medical evaluation. Common signals include:
- Bloating or swelling of the abdomen
- Pelvic or abdominal pain
- Feeling full quickly or difficulty eating
- Urinary urgency or frequency
- Unexplained fatigue
Because symptoms are often vague, being familiar with how your body feels when it’s healthy can help you recognize changes.
🔬 How Ovarian Cancer Is Diagnosed
Diagnosis typically involves a combination of steps:
- Pelvic exam to check for masses.
- Imaging tests (e.g., transvaginal ultrasound, CT scan).
- Blood tests, including tumor markers like CA-125 (although not definitive alone).
- Biopsy or surgery to confirm cancer and determine the specific type and stage.
Early detection deeply influences treatment success; hence, persistent symptoms should always be checked by a healthcare provider.
💊 Conventional Treatment Options
Treatment depends on the type, stage, and individual health factors, often involving:
- Surgery, usually to remove the tumor and any affected tissue.
- Chemotherapy, systemic drug therapy to target cancer cells.
- Targeted therapy and immunotherapy for certain subtypes.
- Radiation therapy in select cases.
Early-stage ovarian cancer has higher survival rates, while advanced stages require more aggressive and often multimodal treatment.
📅 Long-Term & Survivorship Considerations
After treatment, regular follow-up is essential to:
- Monitor for recurrence
- Manage side effects of therapy
- Support overall physical and emotional well-being
Supportive care can include nutritional guidance, physical rehabilitation, stress management, and peer or professional counseling, all coordinated with your oncology care team.
📋 Questions Patients Should Ask Their Healthcare Team
To stay informed and proactive, consider asking your care team:
- What type and stage of ovarian cancer do I have?
- What are my treatment options and the sequence you recommend?
- What are potential side effects and how can they be managed?
- Are there clinical trials suited for me?
- What will follow-up care involve?
🌿 Evidence-Based Non-Toxic & Complementary Therapies
Many women ask what they can do in addition to surgery, chemotherapy, or targeted therapy to improve outcomes, reduce side effects, and support long-term health.
Complementary therapies are not a replacement for standard treatment — but evidence suggests some integrative approaches may improve quality of life, reduce treatment toxicity, and support overall resilience when used safely alongside oncology care.
Below are therapies with meaningful clinical support.
1. Intravenous (IV) Vitamin C
High-dose intravenous vitamin C (ascorbate) achieves pharmacologic blood levels that cannot be reached orally.
What the Research Suggests
- Laboratory studies show pharmacologic vitamin C can generate hydrogen peroxide selectively in tumor tissue.
- Early clinical trials in solid tumors suggest IV vitamin C may:
- Improve quality of life
- Reduce fatigue and chemotherapy-related side effects
- Potentially enhance sensitivity to some therapies
Lymphoma-specific human trials are limited, but mechanistic data suggest a possible benefit in certain molecular subtypes.
Important Considerations
- Should only be administered by trained clinicians
- Must screen for G6PD deficiency
- Should be coordinated with oncology team, especially if receiving RAI or targeted therapy
Ovarian Cancer – Need to Know
Clinical Evidence Showing High-Dose Intravenous Vitamin C (IVC) Can Kill Cancer Cells
2. Metabolic Therapy & Blood Sugar Control
Cancer cells often demonstrate altered glucose metabolism (the “Warburg effect”). While thyroid cancers are generally less metabolically aggressive than many other cancers, insulin resistance and hyperglycemia may still influence outcomes.
Evidence Highlights
- Elevated insulin and IGF-1 signaling are associated with tumor growth in several cancers.
- Obesity is a known risk factor for thyroid cancer and recurrence risk.
- Improved metabolic health supports systemic inflammation control.
Integrative Strategies
- Whole-food, low-glycemic diet
- Reducing refined carbohydrates and ultra-processed foods
- Maintaining healthy body weight
- Monitoring fasting glucose and insulin levels
Some patients explore ketogenic or low-carbohydrate diets. Evidence in thyroid cancer is limited, but metabolic optimization appears beneficial for overall health and survivorship.
Ovarian Cancer – Need to Know
3. The Microbiome & Ovarian Cancer
Emerging research shows gut bacteria influence:
- Immune function
- Inflammation
- Hormone metabolism
- Response to cancer therapy
Microbiome-Supportive Strategies
- High-fiber diet (vegetables, legumes, whole foods)
- Fermented foods (if tolerated)
- Limiting processed foods
- Avoiding unnecessary antibiotics
- Considering targeted probiotic use under guidance
Optimizing gut health may support immune resilience and recovery during survivorship.
The Microbiome and Cancer Care
Prehabilitation is the Gateway to Better Functional Outcomes for Individuals with Cancer
Exercises During Cancer Prehab
🥗 Nutrition & Metabolic Health
While no single “anti-cancer diet” cures ovarian cancer, research consistently shows that metabolic health influences inflammation, immune function, and recurrence risk.
Evidence-based nutrition strategies may include:
- Emphasizing whole, plant-forward foods
- Reducing refined sugars and ultra-processed foods
- Prioritizing fiber, healthy fats, and lean proteins
- Maintaining a healthy body weight
Some emerging research suggests that managing insulin resistance and chronic inflammation may be particularly relevant in ovarian cancer progression.
Patients should consult an oncology-trained dietitian before making major dietary changes during treatment.
Ovarian Cancer – Need to Know
🧘 Exercise & Physical Activity
Regular physical activity is one of the most consistently supported non-toxic interventions in oncology.
Research shows that appropriate exercise during and after treatment can:
- Reduce cancer-related fatigue
- Improve mood and sleep
- Support immune function
- Improve overall survival in several cancers
Even light movement — walking, resistance bands, yoga — can make a meaningful difference when done consistently and safely.
🧠 Stress Reduction & Mind-Body Medicine
A cancer diagnosis is physically and emotionally overwhelming. Chronic stress can influence inflammation and immune regulation.
Evidence-supported stress-reduction tools include:
- Mindfulness meditation
- Guided imagery
- Breathwork
- Yoga
- Cognitive behavioral therapy (CBT)
These approaches have been shown to reduce anxiety, depression, and treatment-related distress — and may improve quality of life during survivorship.
🌞 Vitamin D Optimization
Low vitamin D levels are common in women with ovarian cancer.
Several observational studies suggest that adequate vitamin D levels may be associated with improved outcomes in multiple cancer types, including ovarian cancer. While supplementation is not a cure, testing and correcting deficiency under medical supervision is a low-risk, evidence-informed step.
🧬 Targeted Supplementation (With Medical Supervision)
Some natural compounds are being studied for potential supportive roles in ovarian cancer care, including:
- Omega-3 fatty acids
- Curcumin
- Green tea extract (EGCG)
- Medicinal mushrooms (such as reishi or turkey tail)
Important: Supplements can interact with chemotherapy or targeted therapy. Always discuss supplementation with your oncology team before starting anything new.
💤 Sleep Optimization
Sleep disruption is common during treatment. Poor sleep affects immune regulation, mood, and metabolic function.
Evidence-based sleep strategies include:
- Consistent sleep/wake schedule
- Limiting late-night screen exposure
- Relaxation techniques before bed
- Addressing treatment-related pain or hot flashes
Improving sleep quality is a foundational but often overlooked component of survivorship care.
Ovarian Cancer – Need to Know
⚖️ An Integrative Approach
Integrative oncology focuses on combining the best of conventional treatment with evidence-based lifestyle and supportive therapies.
The goal is not to replace surgery or chemotherapy — but to:
- Reduce toxicity
- Improve treatment tolerance
- Support immune function
- Enhance quality of life
- Address long-term survivorship risks
Every ovarian cancer case is unique. What works for one patient may not be appropriate for another. A personalized plan — ideally developed with both an oncologist and integrative practitioner — provides the safest and most effective path forward.
Citations
-
Cleveland Clinic
Ovarian Cancer: Symptoms, Diagnosis & TreatmentJune 1, 2017 — by I Stage · Cited by 1 — Ovarian cancer accounts for 1% of all new cancer cases in the U.S. The lifetime risk of developing ovarian cancer is approximately 1 in 78.Read more -
Cancer.org
Ovarian Cancer | American Cancer SocietyAug 8, 2025 — Here you can find out all about ovarian cancer, including risk factors, symptoms, how it is found, and how it is treated.Read more -
Ovarian Cancer Research Alliance
Ovarian Cancer: Types, Stages & TreatmentsLearn about the different types of ovarian cancer. Find out how ovarian cancer is diagnosed, understand treatment options, and explore clinical trials. -
Cancer.org
Key Statistics for Ovarian CancerJanuary 13, 2026 — Jan 13, 2026 — A woman’s risk of getting ovarian cancer during her lifetime is about 1 in 91. Her lifetime chance of dying from ovarian cancer is about 1 in …Read more -
Cancer.org
Ovarian Cancer Risk FactorsAug 25, 2025 — Learn about the risk factors for ovarian cancer such as age, obesity, reproductive history, fertility drugs, family history of cancer, … -
Mayo Clinic
Ovarian cancer – Symptoms and causesMay 2, 2025 — Risk factors. Factors that can increase your risk of ovarian cancer include: Older age. The risk of ovarian cancer increases as you age. It’s …Read more -
CDC
Ovarian Cancer Risk FactorsSep 22, 2025 — Most women who get ovarian cancer are not at high risk. · Several factors may increase a woman’s risk for ovarian cancer.Read more -
CDC
Ovarian Cancer BasicsSep 12, 2024 — Treatment works best when ovarian cancer is found in its early stages. Some mutations (changes in genes) can raise your risk for ovarian cancer.Read more -
The Washington Post
Ovarian cancer test may not work on some Black, Native American patientsMarch 22, 2025 — A recent study from the University of Pennsylvania, published in JAMA Network Open, reveals that a standard ovarian cancer test measuring CA-125 protein levels in the blood may be less effective for Black and Native American women. The study analyzed data from over 200,000 ovarian cancer patients between 2004 and 2020 and found that Black and Native American women were 23% less likely to show elevated CA-125 levels when diagnosed, potentially leading to delayed diagnoses. This disparity may stem from earlier research that predominantly involved White participants, although specific racial data were not recorded at the time. Experts, including Alistair Forrest from Australia’s Harry Perkins Institute, emphasize the significance of tailoring diagnostic tools to diverse populations. The findings align with broader research highlighting racial disparities in ovarian cancer outcomes; Black women, for instance, are about 18% more likely to die from the disease than White women, partly due to late-stage diagnoses and differences in care quality. The study calls for more inclusive diagnostic criteria and further research into biological differences in CA-125 expression. While CA-125 testing and transvaginal ultrasounds remain the primary diagnostic tools, experts stress early detection as vital, given ovarian cancer’s often subtle early symptoms and its high mortality rate among women in the U.S.
Ovarian Cancer – Need to Know